2 Followers USX:CRBU - Caribou Biosciences Inc

Caribou Biosciences Inc
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	9.51% -	9.69% 2.0%	15.13% 56.1%	13.31% -12.0%	10.79% -19.0%	10.8% 0.1%	10.82% 0.1%	10.83% 0.1%	13.73% 26.8%	12.43% -9.5%
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-955.31% -	-787.07% -	-697.26% -	-682.39% -	-636.48% -	-714.82% -	-717.79% -	-737.81% -	-780.23% -	-273.19% -	-296.05% -
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-1K% -	-770.12% -	-697.84% -	-699.3% -	-650.58% -	-756.61% -	-768.17% -	-794.21% -	-849.7% -	-315.49% -	-336.63% -
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	5.25M -57.2%	8.02M 53.0%	9.6M 19.6%	10.68M 11.2%	13.39M 25.4%	12.72M -5.0%	13.85M 8.9%	14.69M 6.1%	14.25M -3.0%	34.61M 142.9%	34.48M -0.4%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	158.4M -5.7%	461.96M 191.6%	442.36M -4.2%	446M 0.8%	421.37M -5.5%	398.82M -5.4%	373.76M -6.3%	347.46M -7.0%	349.65M 0.6%	457.52M 30.9%	432.21M -5.5%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	206.09M 1.2%	57.56M -72.1%	54.53M -5.3%	74.2M 36.1%	73.48M -1.0%	74.71M 1.7%	72.89M -2.4%	69.19M -5.1%	80.19M 15.9%	59.25M -26.1%	63.81M 7.7%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-47.69M -	404.4M -	387.82M -4.1%	371.8M -4.1%	347.89M -6.4%	324.11M -6.8%	300.87M -7.2%	278.27M -7.5%	269.46M -3.2%	398.27M 47.8%	368.4M -7.5%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-12.93M -	-19.21M -	-32.52M -	-74.5M -	-79.9M -	-87.31M -	-90.97M -	-97.23M -	-90.54M -	-96.96M -	-93.29M -
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	33.13M -14.7%	24.55M -25.9%	15.95M -35.0%	145.92M 814.7%	129.57M -11.2%	435.36M 236.0%	240.47M -44.8%	147.68M -38.6%	112.19M -24.0%	82.13M -26.8%	58.38M -28.9%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	129.57M -11.2%	435.36M 236.0%	240.47M -44.8%	147.68M -38.6%	112.19M -24.0%	82.13M -26.8%	58.38M -28.9%	52.79M -9.6%	66.24M 25.5%	104.1M 57.2%	51.21M -50.8%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-14.05M -	-22.24M -	-35.64M -	-78.33M -	-85.86M -	-92.99M -	-98.02M -	-105.59M -	-98.84M -	-108.35M -	-104.9M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-50.11M -	-63.15M -	-66.92M -	-72.85M -	-85.24M -	-90.91M -	-99.42M -	-108.38M -	-111.2M -	-94.55M -	-102.07M -
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-50.11M -	-63.15M -	-66.92M -	-72.85M -	-85.24M -	-90.91M -	-99.42M -	-108.38M -	-111.2M -	-94.55M -	-102.07M -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-0.916 -	-1.052 -	-2.11 -	-1.2 -	-1.401 -	-1.1 -	-1.64 -	-1.78 -	-1.83 -	-1.43 -	-1.38 -
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-15.61% -	-36.73% -	-43.35% -	-56.79% -	-24.96% -	-28.87% -	-33.34% -	-36.02% -	-26.18% -	-30.5% -
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-31.63% -	-13.67% -	-27.98% -	-23.73% -	-29.4% -	-21.12% -	-24.36% -	-27.32% -	-28.84% -	-22.08% -	-25.33% -